Completed NA INTERVENTIONAL 1-arm NCT02589041

US-guided Sciatic Nerve Block: Evaluation of the Intraneural Ropivacaine Minimal Effective Volume (MEV90)

Ultrasound-guided Popliteal Sciatic Nerve Block: an Evaluation of the Intraneural

Sponsor: ASST Gaetano Pini-CTO

Conditions US-guided Sciatic Nerve Block

Interventions Ropivacaine 1% intraneural sciatic nerve injection

Updated 7 times since 2017 Last updated: Aug 11, 2017 Started: Nov 30, 2015 Primary completion: Oct 31, 2016 Completion: Apr 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02589041, this NA trial focuses on US-guided Sciatic Nerve Block and remains completed. Sponsored by ASST Gaetano Pini-CTO, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Sep 2017 — Jun 2018 [monthly]

Completed NA

Status: Active Not Recruiting → Completed

▶ Show 2 earlier versions

Feb 2017 — Sep 2017 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Nov 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ASST Gaetano Pini-CTO

Data source: ASST Gaetano Pini-CTO

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Milan, Italy